Dr Reddy News
The company had posted a net profit of Rs 550.39 crore for the corresponding quarter of the previous fiscal, Dr Reddy's Laboratories said in a BSE filing.
Coming down heavily on the I-T Department, CAG has said non-compliance of procedures for giving incentives to pharmaceutical firms, including Ranbaxy, Dr Reddy's and Piramal, resulted Rs 1,348.44 crore loss to the exchequer.
The company had posted a consolidated net profit of Rs 618.42 crore in the October-December period of the previous financial year, it said in a BSE filing.
The tablets are generic version of Roche's Valcyte tablets, it added.
Loading...